© ACCESS Newswire
02.01.2026
EVT
LISTED
XETR
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
News Preview
Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment HAMBURG, DE / ACCESS Newswire / January 2, 2026 / Evotec SE (NASDAQ:EVO; Frankfurt Prime Standard:EVT) today announced the appointment of Dr. Sarah Fakih as Executive Vice President, Head...
Themefolio
Profiler
Peergroup
© EQS Newswire
01.01.2026
EVT
LISTED
XETR
Evotec ernennt Dr. Sarah Fakih als EVP, Leiterin Global Communications und Investor Relations
News Preview
Evotec ernennt Dr. Sarah Fakih als EVP, Leiterin Global Communications und Investor Relations
Neue Executive Vice President-Rolle vereint Global Communications und Investor Relations zur Stärkung strategischer Botschaften und einer klaren Stakeholder-Ansprache
Hamburg, 1. Januar 2026:
Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) gab heute......
Themefolio
Profiler
Peergroup
© EQS Newswire
01.01.2026
EVT
LISTED
XETR
Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
News Preview
Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment
Hamburg, Germany, January 1, 2026:
Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) toda......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
31.12.2025
PCRX
LISTED
TSX
PharmaCorp Announces Grant of Stock Options
News Preview
PHARMACORP ANNOUNCES GRANT OF STOCK OPTIONS...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
31.12.2025
SRPT
LISTED
NASDAQ
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Dec. 31, 2025 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 10 individuals hire...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
XRTX
LISTED
TSX
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
News Preview
Clinical Data doubles known genetic factors associated with urate and Gout Clinical Data doubles known genetic factors associated with urate and Gout...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
AGL
LISTED
NYSE
Investor Notice: Robbins LLP Informs Investors of the Agilon Health, Inc. Securities Class Action
News Preview
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired agilon health, inc. (NYSE: AGL) securities between February 26, 2025 and August 4, 2025. Agilon describes itself as the "trusted partner empowering physicians to transform health care in our communities."
For more informa...
Themefolio
Profiler
Peergroup
© Newsfile
31.12.2025
VIVI
LISTED
CSE
TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea
News Preview
Expansion builds on newly granted South Korean patent, rising local demand and following the launch of digitally connected "VIVI Cap Smart" deviceVancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how tempe...
Themefolio
Profiler
Peergroup
© Newsfile
31.12.2025
IZO
LISTED
CSE
Izotropic Announces AGM Results
News Preview
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - December 31, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
ACH
LISTED
NYSE
Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity
News Preview
Owens & Minor, Inc. (NYSE: OMI) (the “Company”) announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.
“Today’s announcement marks an inflection point in the strategic transfor...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
AGL
LISTED
NYSE
CORRECTING and REPLACING EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of agilon health, inc. Investors – AGL
News Preview
Third paragraph, first sentence of release should read: (1) Defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved... (instead of (1) Defendants recklessly issued guidance for 2026 that they knew or should have known was not going to be achieved...).
The updated release reads:
EQUITY ALE...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
AGL
LISTED
NYSE
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of agilon health, inc. Investors – AGL
News Preview
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for agilon investors under the federal securities...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
31.12.2025
ALVO
LISTED
ICE
Alvotech Secures Term Loan Facility of USD 100 Million
News Preview
REYKJAVIK, ICELAND (December 31, 2025) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term loan facility with maturity in December 2027 aimed at strengthening liquidity and supporting the execution of A...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ALVO
LISTED
ICE
Alvotech Secures Term Loan Facility of USD 100 Million
News Preview
REYKJAVIK, Iceland, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term loan facility with maturity in December 2027 aimed at strengthening liquidity and supporting the...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
OTLK
LISTED
NASDAQ
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
News Preview
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLA...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
AGN
LISTED
CSE
Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing
News Preview
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES...
Themefolio
Profiler
Peergroup
© Newsfile
31.12.2025
HEM
LISTED
TSX
Hemostemix Closes $480,000 Private Placement at $0.12 per Share
News Preview
Calgary, Alberta--(Newsfile Corp. - December 31, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (the "Company" or "Hemostemix"), an autologous stem cell company treating those who suffer in pain from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, dilated cardiomyopathy, total body is...
Themefolio
Profiler
Peergroup
© PR Newswire
31.12.2025
ELAN
LISTED
NYSE
Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis
News Preview
Elanco's second dermatology product approval in less than 18 months in the estimated $1.3 billion U.S. canine dermatology marketBefrena has been shown to be effective for treatment of dogs of any age against canine atopic dermatitis and allergic dermatitis for 6 to 8 weeks of treatment, as neededUSDA approval of Befrena reinforces Elanco's commitm...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
HHL
LISTED
TSX
Harvest ETFs Announces Final Annual 2025 Reinvested ETF Distributions
News Preview
Harvest Portfolios Group Inc. (“Harvest”) today announces the final annual reinvested distributions for Harvest ETFs for the 2025 tax year. Please be advised that the final distributions announced in this press release replace those stated in the November 28, 2025 and December 22, 2025 press releases for the Harvest ETFs.
Each of the Harvest ETF...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ZEAL
LISTED
CPH
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
News Preview
Company announcement – No. 27 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
NPCE
LISTED
NASDAQ
NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference at 3:00pm PT on Wednesday, January 14, 2026, in San Francisco, CA. Management will also host investor meetings during t...
Themefolio
Profiler
Peergroup
© Newsfile
31.12.2025
BUX
LISTED
CSE
BioMark: 2025 Achievements & 2026 Vision
News Preview
Celebrating A Year of Extraordinary AchievementVancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy technologies for early cancer detection, today issued a Year-End Letter to Shareholders and Team...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
CMND
LISTED
NASDAQ
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement
News Preview
Vancouver, Canada, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, announced that it has received a notification...
Themefolio
Profiler
Peergroup
© PR Newswire
31.12.2025
ELDN
LISTED
NASDAQ
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
News Preview
Issued on behalf of Avant Technologies Inc.VANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- USA News Group News Commentary – Recent clinical trials achieving 83% insulin independence rates have ignited a dramatic shift in metabolic disease investment[1], with late-2025 M&A activity reaching record valuations as major pharmaceutical companies race...
Themefolio
Profiler
Peergroup
© PR Newswire
31.12.2025
ELDN
LISTED
NASDAQ
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
News Preview
Issued on behalf of Avant Technologies Inc.VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- USA News Group News Commentary – Recent clinical trials achieving 83% insulin independence rates have ignited a dramatic shift in metabolic disease investment[1], with late-2025 M&A activity reaching record valuations as major pharmaceutical companies race to secu...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
CORT
LISTED
NASDAQ
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
News Preview
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the U.S. Food and Drug Administration (FDA or the Agency) has issu...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
DCTH
LISTED
NASDAQ
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
News Preview
Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of results from subgroup analyses of the phase 3 FOCUS study. The publication, titled “Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepa...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
ESTA
LISTED
NASDAQ
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 44th Annual J.P Morgan Healthcare Con...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ICUI
LISTED
NASDAQ
ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medi...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
FBLG
LISTED
NASDAQ
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
News Preview
HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the filing of a...
Themefolio
Profiler
Peergroup
© PR Newswire
31.12.2025
EXAS
LISTED
NASDAQ
Smart Oncology: 5 Stocks Chasing the $317B Prize
News Preview
Issued on behalf of Oncolytics Biotech Inc.USANewsGroup.com News CommentaryVANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035[1], driven by a fundamental shift in cancer treatment philosophy. Biomarker-guided therapy selection now enables oncology...
Themefolio
Profiler
Peergroup
© PR Newswire
31.12.2025
EXAS
LISTED
NASDAQ
Smart Oncology: 5 Stocks Chasing the $317B Prize
News Preview
Issued on behalf of Oncolytics Biotech Inc.USANewsGroup.com News CommentaryVANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035[1], driven by a fundamental shift in cancer treatment philosophy. Biomarker-guided therapy selection now enables oncology pharmac...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
NOVO B
LISTED
CPH
Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent
News Preview
Today, the Supreme People’s Court in China made a positive decision concerning the intellectual property rights relating to the semaglutide compound patent...
Themefolio
Profiler
Peergroup
© PR Newswire
31.12.2025
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ALLR
LISTED
NASDAQ
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders
News Preview
TARPON SPRINGS, Fla., December 31, 2025 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor—today issued the following letter to shareholders from the Company’s Chief Executive Off...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ABEO
LISTED
NASDAQ
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CLEVELAND, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new executive and non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4)....
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
AXSM
LISTED
NASDAQ
Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation
News Preview
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
BCAB
LISTED
NASDAQ
BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC)
News Preview
SAN DIEGO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, and GATC Health Corp. (GATC), a tech-bio company leveraging artificial intelligence (AI) to transform dr...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
NTRB
LISTED
NASDAQ
Nutriband CEO Publishes Letter to Shareholders
News Preview
Nutriband New Year Letter to Shareholders...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
OGI
LISTED
NASDAQ
Organigram Extends Innovation Investment with Phylos
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share1, today announced the expansion of its innovation investment in Phylos Bioscience Inc. (“Phylos”), securing Organigram’s position as a leader in seed-based cannabis genetics. Through an amended loan and product agreement,...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
AXSM
LISTED
NASDAQ
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission
News Preview
New Drug Application (NDA) submission on track for January 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS31 December 2025 at 13.00 EET ...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
31.12.2025
MODD
LISTED
NASDAQ
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
News Preview
SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today anno...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ALSAF
LISTED
EURONEXT
SAFE : Assemblée Générale - Approbation de l’ensemble des résolutions
News Preview
SAFE...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
SLNO
LISTED
NASDAQ
Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO)
News Preview
The law firm of Kirby McInerney LLP is investigating potential claims against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
[LEARN MORE ABOUT THE...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
INSP
LISTED
NYSE
INSP INVESTORS: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Inspire Medical Systems, Inc.
News Preview
The law firm of Kirby McInerney LLP reminds Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) investors of the January 5, 2026 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Inspire securities between August 6, 2024 through August 4, 2025 (“the Class Period”).
Follow...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
FONR
LISTED
NASDAQ
FONAR Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FONAR Corporation - FONR
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of FONAR Corporation (NasdaqCM: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company. Under the terms of the proposed transaction,...
Themefolio
Profiler
Peergroup
© PR Newswire
31.12.2025
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness
News Preview
WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS™ (tradipitant), an oral neurokinin-1 (NK-1) receptor antagonist, for the prevention of vomiting induced by motion. This approval marks the first new pharmacologic treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.12.2025
ATAI
LISTED
NASDAQ
AtaiBeckley Completes Redomiciliation to the United States
News Preview
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments, today announced the completion of the redomiciliation of the parent company o...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2025
ANIK
LISTED
NASDAQ
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP
News Preview
The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ:ANIK) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGA...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
ALC
LISTED
NYSE
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
News Preview
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.
A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
LH
LISTED
NYSE
Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
BURLINGTON, N.C., Dec. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, at 4:30 p.m. PT....
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
MOH
LISTED
NYSE
Molina Healthcare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call Dates
News Preview
Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the fourth quarter and year ending December 31, 2025, after the market closes on Thursday, February 5, 2026, and will host a conference call and webcast to discuss the earnings release on Friday, February 6, 2026, at 8:00 a.m. Eastern Time. To access this in...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
RVP
LISTED
XASE
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
News Preview
Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends c...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
AIMI
LISTED
OTC
AIM ImmunoTech Announces Stock Dividend
News Preview
OCALA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a stock dividend of one share of common stock for every 1,000 shares of outstanding common stock as well as one share of common stock for every outstanding option or warrant that has a right to receive stock dividends...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
TMDX
LISTED
NASDAQ
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
ANDOVER, Mass., Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44th Annual J.P. Morgan Healthc...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
KRMD
LISTED
NASDAQ
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
News Preview
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the submission of a 510(k) premarket notification to the U.S. Food and Dru...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
HCA
LISTED
NYSE
HCA Healthcare, Inc. 4th Quarter 2025 Earnings Conference Call
News Preview
HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What:
HCA Healthcare, Inc. 4Q 2025 Earnings Call
When:
Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern)
How:
Live Audio over the Internet:
https://investor.hcahealthcare.com/events-and-presentat...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
ALKS
LISTED
NASDAQ
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Tuesday, Jan. 13, 2026 at 10:30 a.m. PST (1:30 p.m. EST/6:30 p.m. GMT). The live webcast may be accessed under the Investo...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.12.2025
AYR.A
LISTED
CSE
AYR Wellness Announces Leadership Update
News Preview
MIAMI, Dec. 30, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that Donna Granato, the Company’s interim Chief Financial Officer (“CFO”), will depart AYR December 31, 2025....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
